How Women's Health Founders Actually Raise, With Dr. Valerie Cai | Blush & Bloom Podcast | Ep. 25

Building a women's health startup is rarely just a matter of a good idea. Founders in this space face a harder funding climate, thornier questions about sensitive data, and a shortage of the operational support that other sectors take for granted.

In this episode of Blush & Bloom, host Gigi Kenneth talks with Dr. Valerie Cai, a clinician, founder, and the person behind XX Combinator, a foundation that supports women's health innovators through the main bottlenecks that stall progress, particularly funding, data, and operational support.

Together they get honest about what still holds the sector back, why Valerie avoids the word femtech, how AI is changing what a non-technical founder can build, and why now, despite everything, is still a compelling time to build for women.

In This Episode, We Cover:

• How a medical student became a founder during COVID, and the pivots that followed
• Why fundraising looks so different for women's health founders, and what actually works
• The three biggest bottlenecks: funding, data, and operational support
• Why Valerie prefers "women's health innovation" over "femtech"
• How AI tools let non-technical founders build a first product cheaply
• The clinical gaps no one is fixing fast enough, from endometriosis meds to the speculum
• What feels different about building in women's health today

From Medical School to Founder

Dr. Valerie Cai describes herself first as a clinician. That is her background and her current work in medical residency. Alongside it, she has always run non-clinical projects, including two startups during medical school and now XX Combinator.

Her route into entrepreneurship started when COVID cleared her calendar in her first year of medical school. An email from her university's entrepreneurship institute landed at the right moment, a friend had a startup to pick back up, and she joined in. That first venture was on urinary catheters, completely unrelated to women's health. A later placement at a mother and baby mental health unit became her gateway into the women's sector.

Why is fundraising so different for women's health founders?

Women's health founders tend to raise less, more slowly, and against steeper expectations, even when they are as qualified and driven as founders in other sectors. Valerie names three compounding factors: it is health tech, the founder is often first-time, and the founder is a woman. Her advice is to stop measuring against the exceptions and rethink what raising should look like for you.

She points out that the headline stories, founders who raise millions pre-product in a few hours, come from a tiny pool of repeat founders with proven track records and de-risked bets.

"These are not realistic expectations for the average female founder to have for themselves."

Instead, she says the more successful founders she sees raise only when they truly need to. They bootstrap from a day job, look at grant funding, or crowdfund, and there is no shame in any of it.

"I think a lot of times founders are just pushed towards VC funding because that's what gets the flashiest headlines."

What are the biggest bottlenecks in women's health startups?

Valerie groups them into three. Funding, where founders often misunderstand the options, timing, and the obligations that come after a raise. Data, where sensitive women's health information carries real safety stakes. And operational support, especially technical operations, where the founder cohort is often non-technical and first-time.

On the obligations of raising, she is blunt that the money is not free.

"As soon as you take someone's money, you're liable for use of that money."

The more you take, she says, the bigger the clock and the faster it ticks, with quarterly investor updates and board dynamics that can steer the business away from the founder's own vision.

🔒 Why Data Strategy Matters More Than Ever

Women's health data is sensitive in a way that has become impossible to ignore. In some places it can be used against women and against the people who provide their care. High-profile lawsuits over data privacy at a well-known period-tracking app, Valerie notes, made the risks concrete for the whole sector.

XX Combinator's response is education. Valerie describes a planned webinar on data strategy from zero to one, covering how to decide what data you actually need, how to store and manage it safely, and how to keep that manageable as it grows, even for pre-product teams.

🤖 How is AI changing what founders can build?

AI tools now shorten the path from idea to a minimum viable product, so a non-technical founder can prototype cheaply and test an idea before spending real money. Valerie points to no-code and prompt-based build tools, pairing them with design tools for the interface, and bringing in a technical person only for tweaks.

Her caution is that women's health founders are not embracing these tools as much as they could, partly because coding was rarely encouraged for girls growing up. And she is clear that a cheap first build is not a reason to chase venture capital straight away.

💗 The Clinical Gaps No One Is Fixing Fast Enough

Valerie sees deep gaps on the clinical side too. Many women's health conditions lack medications developed with those conditions in mind. For endometriosis, for instance, a common management route relies on a device originally developed for contraception, which she says simply is not good enough given how little has gone into dedicated research.

Then there is the speculum, one of her personal interests, a tool designed centuries ago and barely changed since. Newer designs exist, including a lotus-inspired instrument built by women, but she argues the real hurdle is distribution and retraining generations of clinicians. Underneath it sits a harder truth about how the system values women's pain.

"A lot of women's health conditions cause a lot of morbidity, which is time lived in life in pain or poor health that doesn't kill you."

What feels different about building in women's health today?

Compared with a decade ago, there is far more knowledge, interest, and investment in women's health. Compared with about five years ago, at the peak of the femtech boom, investment has actually cooled, tracking a tougher global economy and the fading of an earlier wave of hype-driven funding.

Valerie sees one durable positive: growing awareness that too few women hold check-writing power in venture capital, and a real push for more diverse perspectives among investors. She also notes renewed interest from large funders, much of it flowing into research and development, with the hope it eventually spins into companies, devices, and accessible care.

Why "Women's Health Innovation," Not "Femtech"

Valerie has cooled on the word femtech. Male fertility ended up filed under it, which she finds contradictory, and the "fem" stem itself can feel isolating. She prefers "women's health innovation," partly because medicine already talks about women's health services. She is quick to add she does not think there is a perfect term yet.

FAQ

Who is Dr. Valerie Cai? Dr. Valerie Cai is a clinician and founder, currently in medical residency, and the person behind XX Combinator, a foundation supporting women's health innovators across funding, data, and operational support.

What is XX Combinator? XX Combinator is a foundation that helps women's health founders through the main bottlenecks that stall innovation. It is shifting toward a platform model offering operational support such as education, PR, introductions, and one-off 45-minute strategy sessions for founders. The name plays on the accelerator Y Combinator.

Why do women's health founders find it harder to raise money? Valerie points to three compounding factors: it is health tech, the founder is often first-time, and the founder is a woman. She encourages founders to consider bootstrapping, grants, and crowdfunding rather than defaulting to venture capital.

How can AI help non-technical founders? No-code and prompt-based tools let founders build a basic first version of a product quickly and cheaply, test the core idea, and only later bring in technical help. Valerie cautions that a cheap prototype is not a reason to raise venture capital immediately.

Why does women's health data need a real strategy? Because it is sensitive and, in some contexts, can be used against women and their care providers. Valerie's advice is to decide early what data you actually need, then store and manage it safely from the start.

💬 Final Thoughts

The picture Valerie paints is honest about the obstacles and still, somehow, optimistic. The funding is harder, the data stakes are higher, and the clinical gaps are real, yet the people who keep building in a sector that gets overlooked are, in her words, the more resourceful and dedicated for it. As she puts it, it is more rewarding to build for your passion than for the headlines.

👥 Connect with the Guest

Dr. Valerie Cai: https://www.linkedin.com/in/valerie-cai/

Gigi Kenneth (Host): https://www.linkedin.com/in/gigikenneth

💕 Explore More from Asele

Visit: https://www.asele.tech

Try the Asele app: https://asele.health

Join our WhatsApp community: https://chat.whatsapp.com/F8GY4RV7Bm2CtCfq6TONsV

LinkedIn: https://linkedin.com/company/asele

Spotify: https://open.spotify.com/show/6NEsMfkG3dvl0pYXU40Efi